Abstract
Pancreatic neuroendocrine neoplasms (pNENs) account for approximately 5% of all pancreatic tumors; thus, they constitute the second most common tumor type in the pancreas [...]
Reference28 articles.
1. Trends in the Incidence, Prevalence, and Survival 691 Outcomes in Patients With Neuroendocrine Tumors in the United States;Dasari;JAMA Oncol.,2017
2. Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities 694 for personalized therapies;Arakelyan;Cancer,2021
3. The 2019 WHO classification of tumours of the digestive system;Nagtegaal;Histopathology,2020
4. Lloyd, R.V., Osamura, R.Y., Klöppel, G.N., and Rosai, J. (2017). WHO Classification of Tumours of Endocrine Organs, International Agency for Research on Cancer (IARC). [4th ed.].
5. Gastroenteropancreatic Neuroendocrine Tumors;Cives;CA Cancer J. Clin.,2018